이상반응 보고
| VAERS ID | 1533359 |
|---|---|
| 성별 | 여성 |
| 나이 | |
| 주 코드 | FR |
| 제약회사 | PFIZER\BIONTECH |
| 로트 번호 | |
| 예방접종 횟수 | 1 |
| 접종일 | 2021-04-16 |
| 발병일 | 2021-05-01 |
| 상태 | 사망 |
증상
- 피부질환(Skin disorder)
- 신생물 악성(Neoplasm malignant)
- 신생물 진행(Neoplasm progression)
이환 중 질병
지병
기타 의료
이전 예방접종
알레르기
임상 검사
증상 상세
Skin and subcutaneous tissue disorder; initial and metastatic cancer(aggravation/cause); initial and metastatic cancer(aggravation/cause); This is a spontaneous report from a contactable consumer.
This is second of two reports.
The first report was downloaded from the Regulatory Authority-WEB GR-GREOF-20216150.
A 73-years-old female patient received bnt162b2 (COMIRNATY), dose 1 via an unspecified route of administration on 16Apr2021 (Batch/Lot Number: Unknown) as DOSE 1, SINGLE for covid-19 immunisation.
The patient medical history was not reported.
There were no concomitant medications.
The patient experienced skin and subcutaneous tissue disorder and initial and metastatic cancer(aggravation/cause) on 01May2021.
The events were reported serious with criteria of death and medically significant.
The patient died on 12Jun2021.
It was not reported if an autopsy was performed.
No follow-up attempts are possible; information about lot/batch number cannot be obtained.
No further information is expected.
; Reported Cause(s) of Death: initial and metastatic cancer(aggravation/cause); skin and subcutaneous tissue disorder; initial and metastatic cancer (aggravation/cause)